193 related articles for article (PubMed ID: 37219736)
1. Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Scherschinski L; Han C; Kim YH; Winkler EA; Catapano JS; Schriber TD; Vajkoczy P; Lawton MT; Oh SP
Angiogenesis; 2023 Nov; 26(4):493-503. PubMed ID: 37219736
[TBL] [Abstract][Full Text] [Related]
2. Novel experimental model of brain arteriovenous malformations using conditional Alk1 gene deletion in transgenic mice.
Han C; Lang MJ; Nguyen CL; Luna Melendez E; Mehta S; Turner GH; Lawton MT; Oh SP
J Neurosurg; 2022 Jul; 137(1):163-174. PubMed ID: 34740197
[TBL] [Abstract][Full Text] [Related]
3. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
Brinjikji W; Iyer VN; Wood CP; Lanzino G
J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years.
Brinjikji W; Iyer VN; Yamaki V; Lanzino G; Cloft HJ; Thielen KR; Swanson KL; Wood CP
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1479-86. PubMed ID: 27012295
[TBL] [Abstract][Full Text] [Related]
7. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
[TBL] [Abstract][Full Text] [Related]
8. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.
Park SO; Wankhede M; Lee YJ; Choi EJ; Fliess N; Choe SW; Oh SH; Walter G; Raizada MK; Sorg BS; Oh SP
J Clin Invest; 2009 Nov; 119(11):3487-96. PubMed ID: 19805914
[TBL] [Abstract][Full Text] [Related]
9. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
10. SMAD4 Deficiency Leads to Development of Arteriovenous Malformations in Neonatal and Adult Mice.
Kim YH; Choe SW; Chae MY; Hong S; Oh SP
J Am Heart Assoc; 2018 Nov; 7(21):e009514. PubMed ID: 30571376
[TBL] [Abstract][Full Text] [Related]
11. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.
Han C; Choe SW; Kim YH; Acharya AP; Keselowsky BG; Sorg BS; Lee YJ; Oh SP
Angiogenesis; 2014 Oct; 17(4):823-830. PubMed ID: 24957885
[TBL] [Abstract][Full Text] [Related]
12. De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.
Chen W; Sun Z; Han Z; Jun K; Camus M; Wankhede M; Mao L; Arnold T; Young WL; Su H
Stroke; 2014 Mar; 45(3):900-2. PubMed ID: 24457293
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
[TBL] [Abstract][Full Text] [Related]
14. Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Kim YH; Kim MJ; Choe SW; Sprecher D; Lee YJ; P Oh S
J Thromb Haemost; 2017 Jun; 15(6):1095-1102. PubMed ID: 28339142
[TBL] [Abstract][Full Text] [Related]
15. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
16. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
[TBL] [Abstract][Full Text] [Related]
17. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
Choi EJ; Chen W; Jun K; Arthur HM; Young WL; Su H
PLoS One; 2014; 9(2):e88511. PubMed ID: 24520391
[TBL] [Abstract][Full Text] [Related]
18. Cerebral vascular malformations in hereditary hemorrhagic telangiectasia.
Woodall MN; McGettigan M; Figueroa R; Gossage JR; Alleyne CH
J Neurosurg; 2014 Jan; 120(1):87-92. PubMed ID: 24236651
[TBL] [Abstract][Full Text] [Related]
19. MR angiography for detection of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
Schneider G; Uder M; Koehler M; Kirchin MA; Massmann A; Buecker A; Geisthoff U
AJR Am J Roentgenol; 2008 Apr; 190(4):892-901. PubMed ID: 18356434
[TBL] [Abstract][Full Text] [Related]
20. Brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: clinical presentation and anatomical distribution.
Saleh M; Carter MT; Latino GA; Dirks P; Ratjen F
Pediatr Neurol; 2013 Dec; 49(6):445-50. PubMed ID: 24080277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
